PSB-12379, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase ( CD73 ) inhibitor with K i s of 9.03 nM (rat) and 2.21 nM (human)In VitroMetabolism : Only a small percentage (<23%) of PSB-12379 (10g) is metabolized under the applied conditions, while >77% of the compounds are recovered unchanged after a long incubation for 8 h. PSB-12379 (10g) is somewhat less stable, and 56% are metabolized within 8 h. Hydrolytic cleavage of the glycosidic bond, which is a typical phase I reaction of nucleosides and nucleotides, was observed as the main reaction. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:Ki: 9.03 nM (rat), 2.21 nM (human) (Ecto-5’-Nucleotidase).
Specifications and Purity: ≥99%
Molecular Formula: C18H23N5O9P2
Molecular Weight: 515.35
PubChem CID: 122207761
Isomeric SMILES: C1=CC=C(C=C1)CNC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)COP(=O)(CP(=O)(O)O)O)O)O
- UPC:
- 51171607
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- P649737-25mg
- CAS:
- 1802226-78-3
- Product Size:
- 25mg
akash.verma@cenmed.com
(732) 447-1115





